Michael Gelband’s Arm ARM Stock Holding History

Michael Gelband’s Portfolio ARM Stock Details ARM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21,867	Closed	-$3.54M	–	1516
2025 Q2	$3.54M	Buy	+21,867	New	+$2.71M	0.03%	530
2025 Q1	–	Sell	-20,761	Closed	-$2.56M	–	1441
2024 Q4	$2.56M	Buy	+20,761	New	+$2.93M	0.02%	635
2023 Q4	–	Sell	-143,750	Closed	-$7.69M	–	1444
2023 Q3	$7.69M	Buy	+143,750	New	+$7.95M	0.07%	274

Other funds holding ARM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Michael Gelband's ARM Position: Q3 2025 in Review

Michael Gelband sold out of Arm (ARM) in Q3 2025, closing a stake of 21,867 shares — an estimated $3.54M sold.

Michael Gelband first reported a position in ARM in Q3 2023 and held it in 3 quarters. The position peaked at $7.69M in Q3 2023. 659 funds tracked by Wall St. Rank hold ARM as of Q3 2025.

Michael Gelband reported no remaining Arm position as of Q3 2025 after selling out during the quarter.
Michael Gelband sold 21,867 Arm shares in Q3 2025, an estimated $3.54M.
Michael Gelband first reported a position in Arm in Q3 2023 and held it in 3 quarters.
Michael Gelband's Arm position peaked at $7.69M in Q3 2023.
659 funds tracked by Wall St. Rank held Arm as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.